JP2023546383A5 - - Google Patents
Info
- Publication number
- JP2023546383A5 JP2023546383A5 JP2023521687A JP2023521687A JP2023546383A5 JP 2023546383 A5 JP2023546383 A5 JP 2023546383A5 JP 2023521687 A JP2023521687 A JP 2023521687A JP 2023521687 A JP2023521687 A JP 2023521687A JP 2023546383 A5 JP2023546383 A5 JP 2023546383A5
- Authority
- JP
- Japan
- Prior art keywords
- annexin
- ace2
- composition
- sequence
- inhibits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089584P | 2020-10-09 | 2020-10-09 | |
| US63/089,584 | 2020-10-09 | ||
| PCT/CA2021/051422 WO2022073134A1 (en) | 2020-10-09 | 2021-10-08 | Annexin a5 compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546383A JP2023546383A (ja) | 2023-11-02 |
| JP2023546383A5 true JP2023546383A5 (https=) | 2024-10-17 |
Family
ID=81126326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521687A Pending JP2023546383A (ja) | 2020-10-09 | 2021-10-08 | アネキシンａ５組成物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230374091A1 (https=) |
| JP (1) | JP2023546383A (https=) |
| CA (1) | CA3198378A1 (https=) |
| WO (1) | WO2022073134A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025129329A1 (en) * | 2023-12-23 | 2025-06-26 | London Health Sciences Centre Research Inc. | Methods for treatment of sepsis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002080754A2 (en) * | 2001-04-03 | 2002-10-17 | Theseus Imaging Corporation | Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| DE10145254A1 (de) * | 2001-09-13 | 2003-04-10 | November Ag Molekulare Medizin | Verwendung eines Proteins zur Herstellung eines Medikaments zur Stimulierung einer inflammatorischen zellulären Immunantwort |
| US7452965B2 (en) * | 2002-04-05 | 2008-11-18 | University Of Utah Research Foundation | Colon tumor specific binding peptides |
| EP2349321B1 (en) * | 2008-10-17 | 2020-04-22 | London Health Sciences Centre Research Inc. | Annexin and its use to treat inflammatory disorders |
| WO2022008654A1 (en) * | 2020-07-09 | 2022-01-13 | Exo Biologics Sa | Process for the manufacturing of protein-associated extracellular vesicles |
-
2021
- 2021-10-08 JP JP2023521687A patent/JP2023546383A/ja active Pending
- 2021-10-08 US US18/031,063 patent/US20230374091A1/en active Pending
- 2021-10-08 CA CA3198378A patent/CA3198378A1/en active Pending
- 2021-10-08 WO PCT/CA2021/051422 patent/WO2022073134A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schütz et al. | Peptide and peptide-based inhibitors of SARS-CoV-2 entry | |
| Heinrich et al. | Nanomedicine strategies to target coronavirus | |
| JP2023506765A5 (https=) | ||
| JP2019531763A5 (https=) | ||
| JP2009537143A5 (https=) | ||
| JP2009504157A5 (https=) | ||
| JP2004115529A5 (https=) | ||
| JP2010503396A5 (https=) | ||
| JP2006508193A5 (https=) | ||
| JP2012523438A5 (https=) | ||
| CA2817787C (en) | Composition comprising a peptide and an inhibitor of viral neuraminidase | |
| WO2022010938A3 (en) | Catalysis deactivated angiotensin-converting enzyme 2 (ace2) variants and their uses | |
| JP2023546383A5 (https=) | ||
| US20240218059A1 (en) | TGF-Beta 1 INHIBITORS FOR PREVENTING AND TREATING SARS-COV-2 | |
| WO2022227702A1 (zh) | 一种靶向SARS-CoV-2 N蛋白的干扰肽的制备方法及应用 | |
| JP2023542453A5 (https=) | ||
| Tanaka et al. | A Crispr-Cas9 system designed to introduce point mutations into the human ACE2 gene to weaken the interaction of the ACE2 receptor with the SARS-CoV-2 S protein | |
| F Nahhas et al. | Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics | |
| WO2022094139A1 (en) | Peptide inhibitors for the treatment and prevention of coronavirus infections | |
| MX2022008748A (es) | Administración oral de péptidos. | |
| CN111163792A (zh) | 用于治疗病毒感染的肽 | |
| CA3180858A1 (en) | Peptides for the treatment of covid-19 | |
| JP2005506276A5 (https=) | ||
| JOP20240271A1 (ar) | ببتيدات إظهار أنشطة منع فقدان العضلات وتعزيز الكتلة العضلية واستخداماتها | |
| CN115697385A (zh) | 一种治疗脊髓性肌萎缩症的方法和药物 |